Visualize HL7 Example and Test Instances (vi7eti), pronounced /viːˈsɛtiː/
Disclaimer: FOR TEST AND EXAMPLE PURPOSES ONLY! These web pages are not intended to be used as a source of information on on healthcare or medicines. The web pages are not kept up to date and are for demonstration purposes only. For up-to-date information on a medicine, please consult www.ema.europa.eu/medicines or the package leaflet of your medicine. For up-to-date information on other healthcare topics, please consult the relevant reliable sources or an healthcare expert, such as a physician etc.
BACK TO LIST

Laboratory Report

Patient
Name: Hermighausen, Henryk
DOB: 07-JAN-1964 (Age: 62)
Gender: male
Address:
Scholtzgasse 7472
46325 Borken (Germany)
ID: 8946-366848-6 (ECI)
Report
Date: 24-FEB-2025
Laboratory
dr Ample, Ex
Laboratoire Central Européenne
Boulevard du Jardin Botanique 32
1000 Brussels (Belgium)
Requested by
Marienhospital
46325 Borken (Germany)
Specimen
Collected: 24-FEB-2025

Hematology

Test 24-FEB-2025 Reference Range Unit
Leukocytes [#/volume] in Blood by Automated count 6.9 4.0 - 11.0 10*3/uL
Erythrocytes [#/volume] in Blood by Automated count 5.0 4.3 - 5.7 10*6/uL
Hemoglobin [Mass/volume] in Blood 15.0 13.5 - 17.5 g/dL
Hematocrit [Volume Fraction] of Blood by Automated count 35.4 L 37 - 51 %
MCV [Entitic mean volume] in Red Blood Cells by Automated count 92.5 80 - 100 fL
MCH [Entitic mass] by Automated count 32.2 27 - 33 pg
MCHC [Entitic Mass/volume] in Red Blood Cells by Automated count 34.3 32 - 36 g/dL
Erythrocyte distribution width [Entitic volume] by Automated count 41.4 36 - 48 fL
Platelets [#/volume] in Blood by Automated count 213.1 150 - 450 10*3/uL
Platelet distribution width [Entitic volume] in Blood by Automated count 477.1 H 9.4 - 12.3 fL
Platelet [Entitic mean volume] in Blood by Automated count 9.7 7.4 - 10.4 fL

Chemistry

Test 24-FEB-2025 Reference Range Unit
Hemoglobin A1c/Hemoglobin.total in Blood 6.3 H 4.8 - 5.9 %
Cholesterol [Mass/volume] in Serum or Plasma 229.5 H 125 - 200 mg/dL
Triglyceride [Mass/volume] in Serum or Plasma 324.4 H 0 - 150 mg/dL
Cholesterol in LDL [Mass/volume] in Serum or Plasma by Direct assay 119.9 H 0 - 100 mg/dL
Cholesterol in HDL [Mass/volume] in Serum or Plasma 60.7 H 40 - 60 mg/dL
Glucose [Mass/volume] in Blood 75.7 70 - 100 mg/dL
Urea nitrogen [Mass/volume] in Blood 15.6 7 - 20 mg/dL
Creatinine [Mass/volume] in Blood 2.6 H 0.6 - 1.3 mg/dL
Calcium [Mass/volume] in Blood 9.5 8.5 - 10.5 mg/dL
Sodium [Moles/volume] in Blood 142.4 135 - 145 mmol/L
Potassium [Moles/volume] in Blood 5.2 H 3.5 - 5.1 mmol/L
Chloride [Moles/volume] in Blood 110.4 H 98 - 107 mmol/L
Carbon dioxide, total [Moles/volume] in Blood 21.5 L 22 - 29 mmol/L
Protein [Mass/volume] in Serum or Plasma 6.8 6.6 - 8.3 g/dL
Albumin [Mass/volume] in Serum or Plasma 3.6 3.5 - 5.0 g/dL
Globulin [Mass/volume] in Serum by calculation 3.4 L 25 - 35 g/L
Bilirubin.total [Mass/volume] in Serum or Plasma 0.6 0.2 - 1.2 mg/dL
Alkaline phosphatase [Enzymatic activity/volume] in Serum or Plasma 41.2 39 - 117 U/L
Alanine aminotransferase [Enzymatic activity/volume] in Serum or Plasma 30.5 10 - 40 U/L
Aspartate aminotransferase [Enzymatic activity/volume] in Serum or Plasma 28.6 10 - 40 U/L
Glucose [Mass/volume] in Blood 75.7 70 - 100 mg/dL
Urea nitrogen [Mass/volume] in Blood 15.6 7 - 20 mg/dL
Creatinine [Mass/volume] in Blood 1.1 0.6 - 1.3 mg/dL
Calcium [Mass/volume] in Blood 9.5 8.5 - 10.5 mg/dL
Sodium [Moles/volume] in Blood 142.4 135 - 145 mmol/L
Potassium [Moles/volume] in Blood 5.2 H 3.5 - 5.1 mmol/L
Chloride [Moles/volume] in Blood 110.4 H 98 - 107 mmol/L
Carbon dioxide, total [Moles/volume] in Blood 21.5 L 22 - 29 mmol/L
Cholesterol [Mass/volume] in Serum or Plasma 159.6 125 - 200 mg/dL
Triglyceride [Mass/volume] in Serum or Plasma 102.8 0 - 150 mg/dL
Cholesterol in LDL [Mass/volume] in Serum or Plasma by Direct assay 81.3 0 - 100 mg/dL
Cholesterol in HDL [Mass/volume] in Serum or Plasma 57.8 40 - 60 mg/dL

Annotation

Conclusion and Recommendations based on this report and previous findings known to us
The patient shows evidence of impaired glucose control (elevated HbA1c), dyslipidemia (initially high cholesterol, triglycerides, LDL, and HDL), and mild renal dysfunction (elevated creatinine). Electrolyte disturbances (mild hyperkalemia, hyperchloremia, low CO₂) and a low hematocrit are present. Some parameters improved in a second set (lipids, creatinine). Recommend clinical correlation for diabetes, cardiovascular, and renal risk, and further evaluation of anemia and acid-base status.